The Emerging Role of Natural Killer Cells in Innate and Adaptive Immunity

참고문헌 (103)

1. "Biology of natural killer cells. Adv Immunol 47"
2. "Biology and clinical relevance of human natural killer cells. Blood 76", pp.2421~2438 (1990)
3. "The biology of human natural killer-cell subsets.", 22, pp.633~640 (2001)
4. "A fresh look at tumor immunosurveillance and immunotherapy.", 2, pp.293~299 (2001)
5. "Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.", 319, pp.675~678 (1986)
6. "Receptors for HLA class-I molecules in human natural killer cells.", 14, pp.619~648 (1996)
7. "NK cell receptors.", 16, pp.359~394 (1998)
8. "Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection.", 3, pp.83~90 (2002)
9. "Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat Immunol 1", pp.245~251 (2000)
10. "Lymphocyte development from hematopoietic stem cells. Curr Opin Genet 520-526" (2001)
11. "Murine natural killer cell progenitors and their requirements for development. Semin Immunol 14", pp.453~460 (2002)
12. "Identification of the earliest prethymic bipotent T", NK progenitor in murine fetal liver. Blood 99, 2002, 473~471
13. "Differentiation of NK1.1+ Ly49+ NK cells from flt3+ multipotent marrow progenitor cells. J Immunol 163", puza(v ij), pp.2648~2656 (1999)
14. "Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc Natl Acad Sci USA 99", pp.4526~4531 (2002)
15. "Requirement for membrane lymphotoxin in natural killer cell development. Proc Natl Acad Sci USA 96", pp.6336~6340 (1999)
16. "Fibroblasts from human spleen regulate NK cell differentiation from blood CD34", pp.4326~4332 (2002)
17. "Clonal analysis of NK cell development from bone marrow progenitors in vitro orderly acquisition of receptor gene expression. Eur J Immunol 30", pp.2074~2082 (2000)
18. "Signal via lymphotoxin-beta R on bone marrow stromal cells is required for an early checkpoint of NK cell development. J Immunol 166", pp.1684~1689 (2001)
19. "Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391", pp.700~703 (1998)
20. "Abnormal development of intestinal intraepithelial lymphocytes and peripheral NK cells in mice lacking the IL-2Rb chain. J Exp Med 185", pp.499~505 (1997)
21. "Lack of natural killer cell precursors in fetal liver of Ikaros knockout mutant mice. Nat Immunol 16", pp.137~145 (1998)
22. "Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. Blood 97", pp.2625~2632 (2001)
23. "Commitment to natural killer cells requires the helix-loop- helix inhibitor Id2. Proc Natl Acad Sci USA 98", pp.5164~5169 (2001)
24. "Inhibition of murine erythroleukemia cell differentiation by normal and partially deleted c-myc genes. Immunobiology 185", pp.150~158 (1992)
25. "Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb. Blood 87", pp.2221~2234 (1996)
26. "Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma. Gene Ther Apr 8", pp.542~550 (2001)
27. "The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9", pp.555~563 (1998)
28. "Functional dichotomy in natural killer cell signaling", pp.1 1413~193 1424 (2001)
29. "Clonal acquisition of the Ly49A NK cell receptor is dependent on the trans-acting factor TCF-1. Immunity 11", pp.433~442 (1999)
30. "Redundant functions of TCF-1 and LEF-1 during T and NK cell development but unique role of TCF-1 for Ly49 NK cell receptor acquisition. Eur J Immunol 33", pp.1393~1398 (2003)
31. "The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity 17", pp.437~449 (2002)
32. "VDUP1 is required for the development of natural killer cells. Immunity", in press
33. "Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3", pp.801~809 (1995)
34. "new biology and insights into the graft-versus-leukemia effect. Blood 100" (1935)
35. "a novel triggering surface molecule specifically expressed by activated natural killer cells is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 187", pp.2065~2072 (1998)
36. "New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2", pp.850~861 (2002)
37. "The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol 188", pp.9~21 (2002)
38. "An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285", pp.730~732
39. "receptor complexes in natural killer cells. J Exp Med 192", pp.1059~1068 (2000)
40. "Association of DAP12 with activating CD94", NKG2C NK cell receptors. Immunity 8, 1998, 693~701
41. "bind to CMV glicoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14", pp.123~133 (2001)
42. "Kinetics of interaction of HLA-C ligands with killer cell inhibitory receptors with its biological implications. Immunity 9", pp.337~344 (1998)
43. "HLA-E-bound peptides influence recognition by inhibitory and triggering CD94", NKG2 receptors preferential responses to an HLA-G-derived nonamer. Eur J Immunol 28, 1998, 2854~2863
44. "Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94", NKG2-A and the activating receptor CD94, pp.1999[DOI]
45. "Genomic organization of a human killer cell inhibitory receptor gene. Tissue Antigens 49", pp.574~579 (1997)
46. "Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells", pp.5239~5245
47. "Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur J Immunol 28", pp.264~276 (1998)
48. "CD27-Mediated Activation of Murine NK Cells. J Immunol 164", pp.1741~1745 (2000)
49. "Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells. J Immunol 149", pp.1199~1203 (1992)
50. "NK cell triggering by the human costimulatory molecules CD80 and CD86. J Immunol 163", pp.4207~4212 (1999)
51. "Expression of a variant of CD28 on a subpopulation of human NK cells implications for B7-mediated stimulation of NK cells. J Immunol 163", krivochtchapov l, pp.62~70 (1999)
52. "Absence of B7.1-CD28", CTLA-4-mediated co-stimulation in human NK cells. Eur J Immunol 28, 1998, pp.vuja(vic nl), 780~786
53. "Triggering of Murine NK Cells by CD40 and CD86 . The Journal of Immunology 162", pp.5910~2 5916 (1999)
54. "Antitumor effect of CD40 ligand elicitation of local and systemic antitumor responses by IL-12 and B7. J Immunol 161" (1901)
55. "2B4 functions as a co-receptor in human NK cell activation. Eur J Immunol 30", pp.787~793 (2000)
56. "Interleukin-15 is a novel cytokine which activates human natural killer cells via components of the interleukin-2 receptor. J Exp Med 180", pp.1395~1403 (1994)
57. "A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest 99", pp.937~942 (1997)
58. "Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev 13", pp.155~168 (2002)
59. "immunotherapy for cancer. Cytokine Growth Factor Rev 13", pp.169~183 (2002)
60. "Expression of type 1 cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood 99", pp.1273~13 5 1281 (2002)
61. "Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood 93", pp.1612~1621 (1999)
62. "Sequential production of interferon-gamma by NK1.1 T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 99", pp.1259~1266 (2002)
63. "IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand", pp.1728~1733 (2002)
64. "Interleukin-1β costimulates interferon gamma production by human natural killer cells. Eur J Immunol 31", pp.792~801 (2001)
65. "An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J Exp Med 188", pp.1611~1619 (1998)
66. "TNF-alpha is a principal cytokine involved in the recruitment of NK cells to liver parenchyma. J Immunol 153", pp.333~342 (1994)
67. "cytotoxicity and production of IFN-γ when combined with IL-18. Eur J Immunol 29", pp.2658~2663 (1999)
68. "A distinct IL-18- induced pathway to fully activate NKT lymphocytes indendently from TCR engagement. J Immunol 163", pp.5871~5880 (1999)
69. "IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J Immunol 162", higashi(k), pp.1662~1670 (1999)
70. "The antitumor activity of IL-12 mechanisms of innate immunity that are dose and mod-el dependent. J Immunol 165", pp.2665~2670 (2000)
71. "Differential tumor surveillance by natural killer", pp.191 661~668 (2000)
72. "Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18. Cancer Invest 18", kamido(s), pp.206~211 (2000)
73. "In vivo antitumor effects of murine interferon-γ inducingfactor", interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites. Cancer Immunol Immunother 43, 1997, pp.koh(k), 361~367
74. "Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8", pp.383~390 (1998)
75. "Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity. Gene Ther 19", pp.1672~1680 (2000)
76. "Interleukin-12 and tumor necrosis factor a are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis", pp.3725~3729 (1993)
77. "Comparison of the effects of interleukin-1a interleukin-1b and interferon-γ-inducing factor on the production of interferon-γ by natural killer. Eur J Immunol 27", pp.2787~2792 (1997)
78. "Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nature Med 3", pp.625~631 (1997)
79. "cross-talk relevant in innate anti-tumor immune responses in vivo. Nature Med 5", pp.405~411 (1999)
80. "a mediator of the transition from innate to adaptive immunity. Immunity 16", pp.559~569 (2002)
81. "Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71", pp.173~183 (2002)
82. "CXCL12 expression by invasive trophoblasts induces the specific migration of CD16 negative human natural killer cells. Blood 102", pp.1569~1577 (2003)
83. "IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1. Blood 102", pp.3494~3503 (2003)
84. "and ATAC", lymphotactin function together with IFN-gamma as type 1 cytokines, 2002, 6181~6186
85. "Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD", SCID mice. Blood 102, 1951-19582003, ~
86. "Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr Opin Immunol 12", pp.323~329 (2000)
87. "contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis. J Exp Med 193", pp.661~670 (2001)
88. "Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12. Eur J Immunol 29", pp.1390~1396 (1999)
89. "Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guerin-activated killer cells. Clin Cancer Res 6", pp.3729~3738 (2000)
90. "Perforin expression in T cells and virological response to PEG-interferon alpha2b in HIV-1 infection. AIDS 17", pp.505~511 (2003)
91. "IL-21 induces the functional maturation of murine NK cells. J Immunol Feb 172", pp.2048~2058 (2004)
92. "A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 175", pp.553~566 (1992)
93. "Granzyme M mediates a novel form of perforin-dependent cell death. J Biol Chem 279", pp.22236~22242 (2004)
94. "Caspases are the main executioners of Fas-mediated apoptosis irrespective of the ceramide signalling pathway. Cell Death Differ 5", pp.241~249 (1998)
95. "An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282", pp.121~125 (1998)
96. "Modulation of life and death by the TNF receptor superfamily. Oncogene 17", pp.3261~3270 (1998)
97. "A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. J Immunol 167", pp.2068~2073 (2001)
98. "Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis", pp.583~589 (1999)
99. "NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J Exp Med 200", pp.1325~1335 (2004)
100. "Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 7", pp.94~100 (2001)
101. "Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J Immunol 168", pp.1356~1361 (2002)
102. "NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J Immunol 172", pp.123~129 (2004)
103. "Activation of NK cell cytotoxicity. Mol Immunol 42", pp.501~510 (2005)

관련 논문AI추천